Literature DB >> 1435950

Partial suppression of cell mediated immunity in chromoblastomycosis.

J Fuchs1, S Pecher.   

Abstract

The cellular immune response of 8 patients from the Brazilian Amazon region with chromoblastomycosis was analyzed. Primary immunological responses of patients were tested by contact sensitization to 2,4-dinitro-chlorobenzene (DNCB), or rejection of first set skin allografts. 2 of 8 patients were reactive to DNCB after sensitization, and skin allograft rejection occurred in an average of 14 days. Capacity of patients to mount recall immunological responses was measured by skin testing with two fungal antigens and three bacterial antigens. Delayed skin reaction to trichophytin and candida antigens was negative in the majority of the patients. However, reactivity to mycobacterial (tuberculin), and bacterial (staphylococcal, streptococcal) antigen was high, or only slightly diminished respectively. The data suggest that patients with chromoblastomycosis have suppressed nonspecific, cell mediated immunity for some antigens (skin allografts, DNCB, fungal antigens), while reactivity to bacterial and mycobacterial antigens is not impaired.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435950     DOI: 10.1007/bf00443936

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

1.  Delayed hypersensitivity in experimental fungus infections: the skin reactivity of antigens from the yeast phase of Blastomyces dermatitidis.

Authors:  J E DYSON; E E EVANS
Journal:  J Invest Dermatol       Date:  1955-04       Impact factor: 8.551

2.  The specificity of skin homograft rejection in man.

Authors:  F T RAPAPORT; L THOMAS; J M CONVERSE; H S LAWRENCE
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

3.  Chromoblastomycosis.

Authors:  A L CARRION
Journal:  Ann N Y Acad Sci       Date:  1950-09       Impact factor: 5.691

4.  In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidiodomycosis.

Authors:  C C Musatti; M T Rezkallah; E Mendes; N F Mendes
Journal:  Cell Immunol       Date:  1976-06-15       Impact factor: 4.868

5.  Lymphocyte cultures and skin allograft survival in patients with South American blastomycosis.

Authors:  N F Mendes; C C Musatti; R C Leão; E Mendes; C K Naspitz
Journal:  J Allergy Clin Immunol       Date:  1971-07       Impact factor: 10.793

6.  Quantitative dinitrochlorobenzene contact sensitization in a normal population.

Authors:  W J Catalona; P T Taylor; P B Chretien
Journal:  Clin Exp Immunol       Date:  1972-11       Impact factor: 4.330

7.  Study of humoral and cellular immunity in lobomycosis.

Authors:  S A Pecher; J Croce; R G Ferri
Journal:  Allergol Immunopathol (Madr)       Date:  1979 Nov-Dec       Impact factor: 1.667

8.  A method for dinitrochlorobenzene contact sensitization. A clinicopathological study.

Authors:  W J Catalona; P T Taylor; A S Rabson; P B Chretien
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

9.  Cellular immunity in lobomycosis (keloidal blastomycosis).

Authors:  S A Pecher; J Fuchs
Journal:  Allergol Immunopathol (Madr)       Date:  1988 Nov-Dec       Impact factor: 1.667

10.  Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.

Authors:  M R McGinnis
Journal:  J Am Acad Dermatol       Date:  1983-01       Impact factor: 11.527

View more
  6 in total

Review 1.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media.

Authors:  Valeriano Antonio Corbellini; Maria Lúcia Scroferneker; Mariana Carissimi; Luciane Domingues Santolin
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

4.  Cell-mediated immune responses (CMIR) in human rhinosporidiosis.

Authors:  N R de Silva; H Huegel; D N Atapattu; S N Arseculeratne; R Kumarasiri; S Gunawardena; P Balasooriya; R Fernando
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

5.  Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.

Authors:  C D M P e Silva de Azevedo; O Bruña-Romero; S G Marques; F R F do Nascimento; M C Pinto; L A Silva; L E M Bouillet; F S de Azevedo; M A de Resende Stoianoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-15       Impact factor: 3.267

Review 6.  Chromoblastomycosis in India: Review of 169 cases.

Authors:  Reshu Agarwal; Gagandeep Singh; Arnab Ghosh; Kaushal Kumar Verma; Mragnayani Pandey; Immaculata Xess
Journal:  PLoS Negl Trop Dis       Date:  2017-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.